TG Therapeutics | TGTX - Deudores Comerciales





Deudores Comerciales Cambio Fecha
AbbVie USD 12.59B 180M 2025-12
Alaunos Therapeutics USD 2K 0 2025-06
Amgen USD 9.14B 432M 2026-03
Ardelyx USD 71.85M 4.76M 2025-12
Arrowhead Research USD 15.68M 203.19M 2026-03
Bayer EUR 18.55B 4.36B 2026-03
Biogen USD 1.79B 76.6M 2026-03
Corcept Therapeutics USD 39.07M 20.71M 2026-03
Curis USD 2.55M 400K 2024-06
Gilead Sciences USD 4.74B 172M 2026-03
J&J USD 21.33B 3.72B 2025-12
Karyopharm Therapeutics USD 26.18M 5.6M 2025-12
Novartis USD 9.6B 2.69B 2026-03
Novavax USD 106.45M 72.27M 2025-12
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
TG Therapeutics USD 392.05M 86.42M 2026-03
Verastem USD 9.01M 8.81M 2025-12
Vertex Pharmaceuticals USD 2B 56.7M 2026-03